ドクセピンのヒトヒスタミンH1受容体複合体の構造
Tatsuro Shimamura1, Mitsunori Shiroishi, Simone Weyand
1Human Receptor Crystallography Project, ERATO, Japan Science and Technology Agency, Kyoto 606-8501, Japan.
Nature
|June 24, 2011
まとめ
ドクセピンのヒスタミンH(1) 受容体 (H(1) R) の結晶構造は,ポケットの奥深くにある結合を明らかにします. この構造的洞察は,アレルギーの治療のためのH(1) R抗体の選択性を説明します.
科学分野:
- 構造生物学 構造生物学とは
- 薬理学 薬理学とは
- 薬用化学 薬用化学について
背景:
- ヒスタミンは,アレルギー反応と炎症の重要な媒介体です.
- ヒスタミンH1受容体 (H1R) 抗剤は,アレルギーの症状緩和に不可欠です.
- H(1) R構造を理解することは,選択的対抗体の開発に不可欠です.
研究 の 目的:
- doxepin.1) R複合体の結晶構造をdoxepin.1) R複合体の結晶構造をdoxepin.1) R複合体の結晶構造をdoxepin.1) R複合体の結晶構造をdoxepin.1) R複合体の結晶構造をdoxepin.
- H(1) R抗体選択性の分子基盤を解明する.
- 改善されたH(1) R標的薬の設計のための洞察を提供するために.
主な方法:
- H(1) R-ドクセピン複合体の構造を得るためのX線結晶学.
- 第2世代のH(1) R抗体に対する分子ドッキングシミュレーション.
- アミネルゲン受容体における結合ポケットの特徴の比較分析.
主要な成果:
- ドクセピンはH(1) Rのリガンド結合ポケットの奥深くに結合し,保存された残留物Trp428.8と相互作用する.
- 保存された水性ポケットは,第一世代の抗生物質の選択性が低いことを説明します.
- 第2世代アンタゴニストは,アニオン結合領域でLys191および/またはLys179と相互作用するためにユニークなカルボキシル基を使用します.
- アニオン結合領域は,アミネルゲン受容体間で異なっており,H(1) R抗体選択性に寄与する.
結論:
- この研究は,H(1) R抗体結合と選択性の構造的基礎を明らかにしています.
- アニオン結合領域の差異は,H(1) R抗体の高特異性を達成するために重要である.
- これらの発見は,新しい,選択的なH ((1) Rターゲティング治療法の合理的な設計のための分子基盤を提供します.
関連する概念動画
Dose-Response Relationship: Overview
5.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.2K
Quantitative Aspects of Drug-Receptor Interaction
2.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.2K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.3K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.3K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
3.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
3.2K
Adrenergic Receptors: ɑ Subtype
2.7K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K


